Abstract
Evonik Industries has signed a manufacturing contract to supply AMSilk, a German developer of synthetic spider silk proteins, with product made from the fermentation of renewable raw materials. The agreement is for industrial quantities of the protein, which can be produced as a powder, hydrogel, fiber, or coating. Applications include clothing and coatings for medical implants. Evonik will produce the proteins at its fermentation facility in Slovakia. In 2021, AMSilk raised $35 million in series C funding.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call